These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1525388)

  • 1. Metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in partially hepatectomized rats.
    Maehara Y; Takahashi I; Yoshida M; Emi Y; Baba H; Kusumoto H; Kohnoe S; Sugimachi K
    Anticancer Drugs; 1992 Apr; 3(2):117-20. PubMed ID: 1525388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer.
    Anai H; Sakaguchi Y; Emi Y; Kohnoe S; Maehara Y; Sugimachi K
    Anticancer Drugs; 1991 Jun; 2(3):275-8. PubMed ID: 1802023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolism of tegafur in partial hepatectomized rats].
    Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3078-80. PubMed ID: 3094460
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
    Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
    Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
    Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
    Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tegafur and 5-FU concentrations in cancerous and normal tissues in nude mice after oral administration of UFT].
    Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3265-9. PubMed ID: 3120643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
    Yoshisue K; Kanie S; Nishimura T; Chikamoto J; Nagayama S
    J Pharm Pharmacol; 2009 Dec; 61(12):1643-51. PubMed ID: 19958587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma and tissue concentration of tegafur by a new soft capsule type suppository in colorectal carcinoma].
    Namba M; Muto K; Ikeguchi S; Shida S
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):47-52. PubMed ID: 2492183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of intravenous feeding on adjuvant chemotherapy--an experimental study on the distribution of 5-FU after injection of tegafur (1)].
    Kimoto M; Nagano H; Sano K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):135-9. PubMed ID: 3099649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
    Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
    Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue].
    Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
    Fujii S; Kitano S; Ikenaka K; Shirasaka T
    Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin.
    Peer CJ; McManus TJ; Hurwitz HI; Petros WP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():32-7. PubMed ID: 22565063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial hepatectomy alters sensitivity of rat hepatocytes to 5-fluorouracil.
    Maehara Y; Anai H; Tamada R; Sugimachi K
    Cancer Lett; 1986 Jun; 31(3):227-33. PubMed ID: 3719564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conversion of 1-(2-tetrahydrofuryl-5-fluorouracil (FT-207) into 5-fluorouracil (5-FU) by human maxillary cancer cells (OKK) in culture].
    Yoneda T; Ogawa T; Sakuda M
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1207-8. PubMed ID: 6409001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetic studies on fluorinated pyrimidine in cancer cell and tissue].
    Kanamaru R; Wakui A
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):432-8. PubMed ID: 1558391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the concentration of HCFU, tegafur and 5-FU in the thoracic duct lymph after oral administration of HCFU and tegafur].
    Matsumoto S; Nagai K; Sugimoto T; Kutsuna T; Nomoto S; Yoshizaki S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1697-8. PubMed ID: 3927851
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.